APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anlotinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anlotinib Drugs Market Outlook and Growth Opportunities 2026

Report ID 17396436042 January 2026197 pages

Choose your research edition.

Industry ResearchAnlotinib Drugs Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Anlotinib Drugs Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Anlotinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anlotinib Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anlotinib Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Anlotinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anlotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anlotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anlotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anlotinib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anlotinib Drugs market include CHIA TAI TIANQING. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anlotinib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anlotinib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anlotinib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anlotinib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anlotinib Drugs Segment by Company

CHIA TAI TIANQING

Anlotinib Drugs Segment by Type

8mg Capsules

12mg Capsules

10mg Capsules

Anlotinib Drugs Segment by Application

Hospital

Drugs Store

Anlotinib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anlotinib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anlotinib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anlotinib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Anlotinib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anlotinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anlotinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anlotinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anlotinib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anlotinib Drugs industry.

Chapter 3: Detailed analysis of Anlotinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anlotinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anlotinib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anlotinib Drugs Industry Trends Table 2. Anlotinib Drugs Industry Drivers Table 3. Anlotinib Drugs Industry Opportunities and Challenges Table 4. Anlotinib Drugs Industry Restraints Table 5. Global Anlotinib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anlotinib Drugs Revenue Share by Company (2021-2026) Table 7. Global Anlotinib Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anlotinib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Anlotinib Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anlotinib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anlotinib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Anlotinib Drugs Company, Product Type & Application Table 13. Global Anlotinib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anlotinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 8mg Capsules Table 18. Significant Companies of 12mg Capsules Table 19. Significant Companies of 10mg Capsules Table 20. Global Anlotinib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anlotinib Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Anlotinib Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Anlotinib Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Anlotinib Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Anlotinib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anlotinib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Anlotinib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Anlotinib Drugs Sales Value Share by Type (2021-2026) Table 29. Global Anlotinib Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Drugs Store Table 32. Global Anlotinib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Anlotinib Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Anlotinib Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Anlotinib Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Anlotinib Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Anlotinib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Anlotinib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Anlotinib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Anlotinib Drugs Sales Value Share by Application (2021-2026) Table 41. Global Anlotinib Drugs Sales Value Share by Application (2027-2032) Table 42. Global Anlotinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Anlotinib Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Anlotinib Drugs Sales Market Share by Region (2021-2026) Table 45. Global Anlotinib Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Anlotinib Drugs Sales Market Share by Region (2027-2032) Table 47. Global Anlotinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Anlotinib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Anlotinib Drugs Sales Value Share by Region (2021-2026) Table 50. Global Anlotinib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Anlotinib Drugs Sales Value Share by Region (2027-2032) Table 52. Global Anlotinib Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Anlotinib Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Anlotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Anlotinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Anlotinib Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Anlotinib Drugs Sales Market Share by Country (2021-2026) Table 58. Global Anlotinib Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Anlotinib Drugs Sales Market Share by Country (2027-2032) Table 60. Global Anlotinib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Anlotinib Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Anlotinib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Anlotinib Drugs Sales Value Market Share by Country (2027-2032) Table 64. CHIA TAI TIANQING Company Information Table 65. CHIA TAI TIANQING Business Overview Table 66. CHIA TAI TIANQING Anlotinib Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. CHIA TAI TIANQING Anlotinib Drugs Product Portfolio Table 68. CHIA TAI TIANQING Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Anlotinib Drugs Distributors List Table 72. Anlotinib Drugs Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Anlotinib Drugs Product Image Figure 2. Global Anlotinib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anlotinib Drugs Sales (2021-2032) & (K Units) Figure 5. Global Anlotinib Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anlotinib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 8mg Capsules Image Figure 10. 12mg Capsules Image Figure 11. 10mg Capsules Image Figure 12. Global Anlotinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Anlotinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Anlotinib Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Anlotinib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anlotinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anlotinib Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drugs Store Image Figure 20. Global Anlotinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Anlotinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Anlotinib Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Anlotinib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Anlotinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Anlotinib Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Anlotinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Anlotinib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Anlotinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Anlotinib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Anlotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Anlotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Anlotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Anlotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Anlotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Anlotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Anlotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Anlotinib Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Anlotinib Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg Capsules
  • 12mg Capsules
  • 10mg Capsules
Applications
  • Hospital
  • Drugs Store
Companies covered
  • CHIA TAI TIANQING

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anlotinib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Anlotinib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Anlotinib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anlotinib Drugs Market Dynamics
  1. 2.1 Anlotinib Drugs Industry Trends
  2. 2.2 Anlotinib Drugs Industry Drivers
  3. 2.3 Anlotinib Drugs Industry Opportunities and Challenges
  4. 2.4 Anlotinib Drugs Industry Restraints
3 Anlotinib Drugs Market by Company
  1. 3.1 Global Anlotinib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Anlotinib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Anlotinib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Anlotinib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Anlotinib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Anlotinib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Anlotinib Drugs Company Product Type and Application
  8. 3.8 Global Anlotinib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anlotinib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anlotinib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anlotinib Drugs Market by Type
  1. 4.1 Anlotinib Drugs Type Introduction
  2. 4.1.1 8mg Capsules
  3. 4.1.2 12mg Capsules
  4. 4.1.3 10mg Capsules
  5. 4.2 Global Anlotinib Drugs Sales Volume by Type
  6. 4.2.1 Global Anlotinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anlotinib Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Anlotinib Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Anlotinib Drugs Sales Value by Type
  10. 4.3.1 Global Anlotinib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anlotinib Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Anlotinib Drugs Sales Value Share by Type (2021-2032)
5 Anlotinib Drugs Market by Application
  1. 5.1 Anlotinib Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Anlotinib Drugs Sales Volume by Application
  5. 5.2.1 Global Anlotinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anlotinib Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Anlotinib Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Anlotinib Drugs Sales Value by Application
  9. 5.3.1 Global Anlotinib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anlotinib Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Anlotinib Drugs Sales Value Share by Application (2021-2032)
6 Anlotinib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Anlotinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anlotinib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anlotinib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Anlotinib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Anlotinib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anlotinib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anlotinib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anlotinib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Anlotinib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anlotinib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Anlotinib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anlotinib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Anlotinib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anlotinib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anlotinib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anlotinib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Anlotinib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anlotinib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anlotinib Drugs Sales Value Share by Country, 2025 VS 2032
7 Anlotinib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Anlotinib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anlotinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anlotinib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Anlotinib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Anlotinib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Anlotinib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anlotinib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anlotinib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anlotinib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anlotinib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anlotinib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CHIA TAI TIANQING
  2. 8.1.1 CHIA TAI TIANQING Company Information
  3. 8.1.2 CHIA TAI TIANQING Business Overview
  4. 8.1.3 CHIA TAI TIANQING Anlotinib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CHIA TAI TIANQING Anlotinib Drugs Product Portfolio
  6. 8.1.5 CHIA TAI TIANQING Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anlotinib Drugs Value Chain Analysis
  2. 9.1.1 Anlotinib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anlotinib Drugs Sales Mode & Process
  6. 9.2 Anlotinib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anlotinib Drugs Distributors
  9. 9.2.3 Anlotinib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst